Arteriosclerosis and Thrombosis, Vol 11, 476-481, Copyright © 1991 by American Heart Association

ARTICLES

Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition

R McPherson, M Hogue, RW Milne, AR Tall and YL Marcel
Lipid Research Laboratory, Royal Victoria Hospital, McGill University, Montreal, Canada.

Probucol is a hypolipidemic agent that causes a marked decrease in high density lipoprotein (HDL) cholesterol. To investigate the mechanism of this effect, two studies were performed in hypercholesterolemic patients who had been stabilized previously on diet and were not receiving other lipid-lowering medication. Plasma cholesteryl ester transfer protein (CETP) concentrations were measured in fasting plasma samples before and after 10 weeks of probucol therapy using a sensitive and specific radioimmunoassay. Plasma total and low density lipoprotein cholesterol concentrations decreased, whereas apolipoprotein (apo) B was unchanged. Plasma apo E concentrations increased markedly. HDL cholesterol and apo A-I decreased in all subjects. These effects of probucol were accompanied by even more striking changes in plasma CETP concentrations, which increased by a mean of 64%. In a second study of six hypercholesterolemic subjects, the time-course effects of probucol on CETP and HDL subspecies were studied. Significant increases in plasma apo E and in CETP occurred after 4 weeks, and CETP, but not apo E, increased further after 16 weeks of treatment. Concomitant and opposite changes occurred in HDL composition, with decreases in HDL cholesterol and lipoprotein containing apo A-I. The increase in plasma CETP concentrations, the decrease in HDL cholesterol, and the increase in plasma apo E concentrations observed during probucol treatment are changes consistent with a postulated increase in reverse cholesterol transport via the remnant pathway.

This article has been cited by other articles:

				R. Arakawa, M. Tsujita, N. Iwamoto, C. Ito-Ohsumi, R. Lu, C.-A. Wu, K. Shimizu, T. Aotsuka, H. Kanazawa, S. Abe-Dohmae, et al. Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis J. Lipid Res., November 1, 2009; 50(11): 2299 - 2305. [Abstract] [Full Text] [PDF]

				C. Harder, P. Lau, A. Meng, S. C. Whitman, and R. McPherson Cholesteryl Ester Transfer Protein (CETP) Expression Protects Against Diet Induced Atherosclerosis in SR-BI Deficient Mice Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 858 - 864. [Abstract] [Full Text] [PDF]

				F. Rinninger, N. Wang, R. Ramakrishnan, X. C. Jiang, and A. R. Tall Probucol Enhances Selective Uptake of HDL-Associated Cholesteryl Esters In Vitro by a Scavenger Receptor B-I–Dependent Mechanism Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1325 - 1332. [Abstract] [Full Text] [PDF]

				M. H. Moghadasian, B. M. McManus, D. V. Godin, B. Rodrigues, and J. J. Frohlich Proatherogenic and Antiatherogenic Effects of Probucol and Phytosterols in Apolipoprotein E–Deficient Mice : Possible Mechanisms of Action Circulation, April 6, 1999; 99(13): 1733 - 1739. [Abstract] [Full Text] [PDF]

				K. Sasai, K. Okumura-Noji, T. Hibino, R. Ikeuchi, N. Sakuma, T. Fujinami, and S. Yokoyama Human cholesteryl ester transfer protein measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cholesteryl ester transfer protein: plasma cholesteryl ester transfer protein and lipoproteins among Japanese hypercholesterolemic patients Clin. Chem., July 1, 1998; 44(7): 1466 - 1473. [Abstract] [Full Text] [PDF]

				D. Steinberg Lewis A. Conner Memorial Lecture: Oxidative Modification of LDL and Atherogenesis Circulation, February 18, 1997; 95(4): 1062 - 1071. [Full Text]

				M. L. Hannuksela, M. Rantala, Y. A. Kesaniemi, and M. J. Savolainen Ethanol-Induced Redistribution of Cholesteryl Ester Transfer Protein (CETP) Between Lipoproteins Arterioscler Thromb Vasc Biol, February 1, 1996; 16(2): 213 - 221. [Abstract] [Full Text]

				F.ço. Gaudet and G. S. Ginsburg Transcriptional Regulation of the Cholesteryl Ester Transfer Protein Gene by the Orphan Nuclear Hormone Receptor Apolipoprotein AI Regulatory Protein-1 J. Biol. Chem., December 15, 1995; 270(50): 29916 - 29922. [Abstract] [Full Text] [PDF]

				T. Murakami, S. Michelagnoli, R. Longhi, G. Gianfranceschi, F. Pazzucconi, L. Calabresi, C. R. Sirtori, and G. Franceschini Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1819 - 1828. [Abstract] [Full Text]

				F. Tato, G. L. Vega, and S. M. Grundy Bimodal Distribution of Cholesteryl Ester Transfer Protein Activities in Normotriglyceridemic Men With Low HDL Cholesterol Concentrations Arterioscler Thromb Vasc Biol, April 1, 1995; 15(4): 446 - 451. [Abstract] [Full Text]